Adenylyl cyclase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
<StructureSection load='' size='300' side='right' scene='Sandbox_159/Main_1y11/1' caption=''>
<StructureSection load='' size='300' side='right' scene='Sandbox_159/Main_1y11/1' caption=''>
-
[[Adenylyl cyclase]] (ADCY, EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.6.1.1 4.6.1.1]), also known as adenylate cyclase, is an enzyme which catalyzes the cyclization of <scene name='Adenylyl_cyclase/Cv/7'>adenosine triphosphate (ATP)</scene> into <scene name='Adenylyl_cyclase/Cv/8'>cyclic adenosine monophosphate (cAMP) which requires the cleavage of pyrophosphate (PPi)</scene> <ref name="Taussig">PMID:7814360</ref>. The <scene name='Adenylyl_cyclase/Cv/9'>reaction</scene> occurs in a single, concerted step, where the oxygen on ATP's 3' hydroxyl group nucleophillically attacks the alpha-phosphate forming a phosphodiester bond and cleaving a pyrophosphate group<ref name="Hurley">PMID:10075642</ref>. In most active sites there is an acidic residue near the 3'OH which functions in its deprotonation, and basic residues by the β-phosphorous to lower the energy of the group for cleavage<ref name="Zhang">PMID:9069282</ref><ref>PMID:14747729</ref>. The reactant in the reaction catalyzed by adenylyl cyclase is ATP; ATP is the most abundant nucleotide triphosphate in most cells with typical concentrations ranging from 1 to 10mM<ref>PMID:1212224</ref>. This high intracellular concentration allows for cAMP concentrations to rise quickly in response to a specific signal, which is important in many signal transduction and metabolic pathways<ref>PMID:182581</ref>. The main product of this reaction is cAMP, with a side product of PP<sub>i</sub><ref name="Taussig"/>. The cytoplasmic regions of ADCY consist of its N-terminal, C1a, C1b, C2a and C2b. The C1a and C2a make the catalytic domain. This page emphasizes on the microbial adenylyl cyclase Rv1264, but mammalian adenylyl cyclases are also covered in less detail.<br />
+
[[Adenylyl cyclase]] (ADCY, EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.6.1.1 4.6.1.1]), also known as adenylate cyclase, is an enzyme which catalyzes the cyclization of <scene name='Adenylyl_cyclase/Cv/7'>adenosine triphosphate (ATP)</scene> into <scene name='Adenylyl_cyclase/Cv/8'>cyclic adenosine monophosphate (cAMP) which requires the cleavage of pyrophosphate (PPi)</scene> <ref name="Taussig">PMID:7814360</ref>. The <scene name='Adenylyl_cyclase/Cv/9'>reaction</scene> occurs in a single, concerted step, where the oxygen on ATP's 3' hydroxyl group nucleophillically attacks the alpha-phosphate forming a phosphodiester bond and cleaving a pyrophosphate group<ref name="Hurley">PMID:10075642</ref>. In most active sites there is an acidic residue near the 3'OH which functions in its deprotonation, and basic residues by the β-phosphorous to lower the energy of the group for cleavage<ref name="Zhang">PMID:9069282</ref><ref>PMID:14747729</ref>. The reactant in the reaction catalyzed by adenylyl cyclase is ATP; ATP is the most abundant nucleotide triphosphate in most cells with typical concentrations ranging from 1 to 10mM<ref>PMID:1212224</ref>. This high intracellular concentration allows for cAMP concentrations to rise quickly in response to a specific signal, which is important in many signal transduction and metabolic pathways<ref>PMID:182581</ref>. The main product of this reaction is cAMP, with a side product of PP<sub>i</sub><ref name="Taussig"/>. The cytoplasmic regions of ADCY consist of its N-terminal, C1a, C1b, C2a and C2b. The C1a and C2a make the catalytic domain. This page emphasizes on the microbial adenylyl cyclase Rv1264, but mammalian adenylyl cyclases are also covered in less detail.
-
 
+
[[Image:CAMP synthesis.png|400px|thumb|left]]
-
[[Image:CAMP synthesis.png|400px|thumb|left]]<br />
+
-
<br />
+
-
<br />
+
{{Clear}}
{{Clear}}
Line 23: Line 20:
=== Type II ===
=== Type II ===
==== Structure ====
==== Structure ====
-
<applet load='1ab8' size='400' frame='true' align='right' caption='Type II adenylyl cyclase homodimer with two bound forskolin molecules' scene='Sandbox_159/Full_structure_1ab8/1'/>
+
A monomer of C<sub>2</sub> domain of <scene name='Sandbox_159/Full_structure_1ab8/1'>type II adenylyl cyclase</scene> has an internal, hydrophobic, anti-parallel <scene name='Adenylyl_cyclase/Beta_sheets_1ab8/1'>β-sheet</scene> surrounded by several, amphipathic <scene name='Adenylyl_cyclase/Helix_1ab8/1'>α-helices</scene>, except for an area which needed to form a homodimer with another C<sub>2</sub> domain<ref name="Zhang"/>. Two monomers of C<sub>2</sub> domains of type II adenylyl cyclase bind together in solution to form a <scene name='Adenylyl_cyclase/Full_structure_1ab8/1'>Homodimer</scene>, which is necessary for catalytic conversion of ATP to cAMP and PPi<ref name="Hurley"/>. When they are bound they create a deep crevasse spanning the center of their binding site; this crevasse is suited to bind two <scene name='Adenylyl_cyclase/Forskolin_1ab8/1'>forskolin</scene> molecules at its ends<ref name="Tesmer">PMID:9417641</ref>. Strong hydrogen bonds are made between oxygen atoms of forskolin and the surrounding peptide backbone, and the rest of the interactions are highly hydrophobic, as the forskolin binding site contains ten aliphatic and aromatic residues<ref name="Tesmer"/>. This binding of forskolin creates a hydrophobic linkage between the monomers, each of which has two different hydrophobic surfaces binding to forskolin; and it is this interaction which makes the homodimer stable<ref name="Zhang"/><ref name="Tesmer"/>. The forskolin also interacts with and properly positions Asn 1025, which is essential for catalytic activity, and it may even interact directly with the ATP<ref name="Tesmer"/>. This homodimer-forskolin complex can be further activated in response to a signal via binding to a G-protein’s βγ-subunit <ref name="Hurley"/><ref name="Tesmer"/>. This βγ-subunit binds to <scene name='Adenylyl_cyclase/G-protein_binding_site/1'>residues 956 to 982</scene> which make up part of an α-helix on the outermost layer of the complex<ref name="Hurley"/><ref>PMID:2899356</ref>.
-
A monomer of C<sub>2</sub> domain of type II adenylyl cyclase has an internal, hydrophobic, anti-parallel <scene name='Adenylyl_cyclase/Beta_sheets_1ab8/1'>β-sheet</scene> surrounded by several, amphipathic <scene name='Adenylyl_cyclase/Helix_1ab8/1'>α-helices</scene>, except for an area which needed to form a homodimer with another C<sub>2</sub> domain<ref name="Zhang"/>. Two monomers of C<sub>2</sub> domains of type II adenylyl cyclase bind together in solution to form a <scene name='Adenylyl_cyclase/Full_structure_1ab8/1'>Homodimer</scene>, which is necessary for catalytic conversion of ATP to cAMP and PPi<ref name="Hurley"/>. When they are bound they create a deep crevasse spanning the center of their binding site; this crevasse is suited to bind two <scene name='Adenylyl_cyclase/Forskolin_1ab8/1'>forskolin</scene> molecules at its ends<ref name="Tesmer">PMID:9417641</ref>. Strong hydrogen bonds are made between oxygen atoms of forskolin and the surrounding peptide backbone, and the rest of the interactions are highly hydrophobic, as the forskolin binding site contains ten aliphatic and aromatic residues<ref name="Tesmer"/>. This binding of forskolin creates a hydrophobic linkage between the monomers, each of which has two different hydrophobic surfaces binding to forskolin; and it is this interaction which makes the homodimer stable<ref name="Zhang"/><ref name="Tesmer"/>. The forskolin also interacts with and properly positions Asn 1025, which is essential for catalytic activity, and it may even interact directly with the ATP<ref name="Tesmer"/>. This homodimer-forskolin complex can be further activated in response to a signal via binding to a G-protein’s βγ-subunit <ref name="Hurley"/><ref name="Tesmer"/>. This βγ-subunit binds to <scene name='Adenylyl_cyclase/G-protein_binding_site/1'>residues 956 to 982</scene> which make up part of an α-helix on the outermost layer of the complex<ref name="Hurley"/><ref>PMID:2899356</ref>.
+
The <scene name='Adenylyl_cyclase/Activesite_1ab8/1'>active site</scene> of this homodimer is located within the crevasse, and is characterized by two highly conserved sets of polar residues (Arg 997 (Green), Asn 1025 (Red), Ser1028(Pink), Arg 1029(Orange), Asp 1031(Yellow), and Ser 1032(Purple))<ref name="Hurley"/><ref name="Zhang"/>. One of these sets is located on each monomeric subunit, on the homodimer they arrange themselves in an anti-parallel fashion, where they point towards each other<ref name="Zhang"/>.
The <scene name='Adenylyl_cyclase/Activesite_1ab8/1'>active site</scene> of this homodimer is located within the crevasse, and is characterized by two highly conserved sets of polar residues (Arg 997 (Green), Asn 1025 (Red), Ser1028(Pink), Arg 1029(Orange), Asp 1031(Yellow), and Ser 1032(Purple))<ref name="Hurley"/><ref name="Zhang"/>. One of these sets is located on each monomeric subunit, on the homodimer they arrange themselves in an anti-parallel fashion, where they point towards each other<ref name="Zhang"/>.

Revision as of 13:06, 15 November 2012

Drag the structure with the mouse to rotate

Contents

Biological Role

M. tuberculosis is a pathogenic bacterium, and thus it faces an array of a host's immune responses to attempt in an attempt to rid of it[20]. One of the hosts defense mechanisms M. tuberculosis faces is acidification encountered in phagolysosomes. The ability to be able to detect this acidic environment, and have an appropriate response to it may greatly assist M. tuberculosis infect a host[21][22]. As cAMP levels are increased, acidification of other structures is delayed and elevated cAMP levels activate cAMP receptor proteins which in turn regulate transcription[23][24].

3D Structures of Adenylyl cyclase

2ev1, 2ev2, 2ev3, 2ev4 – MtADCY N-terminal – Mycobacterium tuberculosis
1y10, 1y11 – MtADCY holoenzyme
2fjt – ADCY 4 – Yersinia pestis
1ykd – ADCY – Anabaena
1ab8 – ADCY C2 domain - rat

ADCY catalytic domain

1yk9, 1ybt, 1ybu – MtADCY catalytic domain
1fx2, 1fx4 - ADCY catalytic domain – Trypanosoma brucei
2bw7 - SpADCY catalytic domain+catechol estrogen – Spirulina platensis
1wc0 – SpADCY catalytic domain+methylene ATP
1wc1, 1wc3, 1wc4, 1wc5, 1wc6 - SpADCY catalytic domain+ATP derivatives
3maa – dADCY 5 (mutant)+ADCY 2 C2a+guanine nucleotide binding protein G – dog
3g82 - dADCY 5 (mutant)+ADCY 2 C1a+guanine nucleotide binding protein G
3c14, 3c15 - dADCY 5 C1a (mutant)+ADCY 2 C2a+guanine nucleotide binding protein G+PPi+ions
3c16 - dADCY 5 C1a (mutant)+ADCY 2 C2a+guanine nucleotide binding protein G+ATP+Ca
2gvd, 2gvz - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+ATP+Mn
1tl7, 1u0h - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+GTP+Mn
1cs4 - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+AMP+Mg+PPI+GDP
1cul - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+GDP+Mg+triphosphate
1cjk - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+ATP+Mn+Mg
1cjt - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+GDP+Mn+Mg+ATP
1cju - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+GDP+Mg+ATP
1cjv - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+GDP+Mg+Zn+ATP
1azs - dADCY 5 C1a +ADCY 2 C2a+guanine nucleotide binding protein G+GDP+Mg
1yrt, 1yru - ADCY catalytic domain+calmodulin C-terminal – Bordetella pertussis

ADCY anthrax edema factor associated domain

1k8t - BaADCY C-terminal - Bacillus anthracis
1lvc, 1pk0, 1s26 – BaADCY C-terminal+calmodulin+anthranyloyl ATP+Yb+Ca
1sk6 - BaADCY C-terminal+calmodulin+cAMP+PPi
1xfu - BaADCY C-terminal (mutant)+calmodulin
1xfv, 1k90 - BaADCY C-terminal+calmodulin+dATP
1xfw - BaADCY C-terminal+calmodulin+cAMP
1xfx, 1xfz - BaADCY C-terminal+calmodulin+Ca
1xfy, 1k93 - BaADCY C-terminal+calmodulin
1y0v - BaADCY C-terminal+calmodulin+PPi

References

  1. 1.0 1.1 1.2 1.3 1.4 Taussig R, Gilman AG. Mammalian membrane-bound adenylyl cyclases. J Biol Chem. 1995 Jan 6;270(1):1-4. PMID:7814360
  2. 2.0 2.1 2.2 2.3 2.4 Hurley JH. Structure, mechanism, and regulation of mammalian adenylyl cyclase. J Biol Chem. 1999 Mar 19;274(12):7599-602. PMID:10075642
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 Zhang G, Liu Y, Ruoho AE, Hurley JH. Structure of the adenylyl cyclase catalytic core. Nature. 1997 Mar 20;386(6622):247-53. PMID:9069282 doi:10.1038/386247a0
  4. Ketkar AD, Shenoy AR, Kesavulu MM, Visweswariah SS, Suguna K. Purification, crystallization and preliminary X-ray diffraction analysis of the catalytic domain of adenylyl cyclase Rv1625c from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr. 2004 Feb;60(Pt 2):371-3. Epub 2004, Jan 23. PMID:14747729 doi:10.1107/S0907444903028002
  5. Beis I, Newsholme EA. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J. 1975 Oct;152(1):23-32. PMID:1212224
  6. Haring HU, Renner R, Hepp KD. Hormonal control of cyclic AMP turnover in isolated fat cells. Mol Cell Endocrinol. 1976 Aug-Sep;5(3-4):295-302. PMID:182581
  7. Pastor-Soler N, Beaulieu V, Litvin TN, Da Silva N, Chen Y, Brown D, Buck J, Levin LR, Breton S. Bicarbonate-regulated adenylyl cyclase (sAC) is a sensor that regulates pH-dependent V-ATPase recycling. J Biol Chem. 2003 Dec 5;278(49):49523-9. Epub 2003 Sep 25. PMID:14512417 doi:10.1074/jbc.M309543200
  8. 8.0 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 Linder JU, Schultz A, Schultz JE. Adenylyl cyclase Rv1264 from Mycobacterium tuberculosis has an autoinhibitory N-terminal domain. J Biol Chem. 2002 May 3;277(18):15271-6. Epub 2002 Feb 11. PMID:11839758 doi:10.1074/jbc.M200235200
  9. 9.0 9.1 9.2 Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R, van Rijn L, Gaspar C, Fodde R, Janssen F, van Blitterswijk C, de Boer J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A. 2008 May 20;105(20):7281-6. Epub 2008 May 19. PMID:18490653
  10. Cox RP, Gilbert P Jr, Griffin MJ. Alkaline inorganic pyrophosphatase activity of mammalian-cell alkaline phosphatase. Biochem J. 1967 Oct;105(1):155-61. PMID:4964763
  11. Boyer PD. The ATP synthase--a splendid molecular machine. Annu Rev Biochem. 1997;66:717-49. PMID:9242922 doi:10.1146/annurev.biochem.66.1.717
  12. 12.0 12.1 Feinstein PG, Schrader KA, Bakalyar HA, Tang WJ, Krupinski J, Gilman AG, Reed RR. Molecular cloning and characterization of a Ca2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10173-7. PMID:1719547
  13. 13.0 13.1 13.2 13.3 13.4 Tesmer JJ, Sunahara RK, Gilman AG, Sprang SR. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science. 1997 Dec 12;278(5345):1907-16. PMID:9417641
  14. Masters SB, Sullivan KA, Miller RT, Beiderman B, Lopez NG, Ramachandran J, Bourne HR. Carboxyl terminal domain of Gs alpha specifies coupling of receptors to stimulation of adenylyl cyclase. Science. 1988 Jul 22;241(4864):448-51. PMID:2899356
  15. 15.0 15.1 15.2 15.3 15.4 Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, Vijayraghavan S, Brennan A, Dudley A, Nou E, Mazer JA, McCormick DA, Arnsten AF. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007 Apr 20;129(2):397-410. PMID:17448997 doi:10.1016/j.cell.2007.03.015
  16. 16.00 16.01 16.02 16.03 16.04 16.05 16.06 16.07 16.08 16.09 16.10 16.11 16.12 16.13 16.14 16.15 16.16 16.17 16.18 16.19 16.20 16.21 16.22 16.23 16.24 16.25 16.26 16.27 16.28 16.29 16.30 16.31 16.32 16.33 16.34 16.35 16.36 Tews I, Findeisen F, Sinning I, Schultz A, Schultz JE, Linder JU. The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme. Science. 2005 May 13;308(5724):1020-3. PMID:15890882 doi:http://dx.doi.org/308/5724/1020
  17. 17.0 17.1 17.2 Tesmer JJ, Sunahara RK, Johnson RA, Gosselin G, Gilman AG, Sprang SR. Two-metal-Ion catalysis in adenylyl cyclase. Science. 1999 Jul 30;285(5428):756-60. PMID:10427002
  18. Tesmer JJ, Dessauer CW, Sunahara RK, Murray LD, Johnson RA, Gilman AG, Sprang SR. Molecular basis for P-site inhibition of adenylyl cyclase. Biochemistry. 2000 Nov 28;39(47):14464-71. PMID:11087399
  19. 19.0 19.1 19.2 19.3 19.4 19.5 19.6 19.7 19.8 Findeisen F, Linder JU, Schultz A, Schultz JE, Brugger B, Wieland F, Sinning I, Tews I. The structure of the regulatory domain of the adenylyl cyclase Rv1264 from Mycobacterium tuberculosis with bound oleic acid. J Mol Biol. 2007 Jun 22;369(5):1282-95. Epub 2007 Apr 12. PMID:17482646 doi:10.1016/j.jmb.2007.04.013
  20. Glickman MS, Jacobs WR Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell. 2001 Feb 23;104(4):477-85. PMID:11239406
  21. Channon JY, Kasper LH. Parasite subversion of the host cell endocytic network. Parasitol Today. 1995 Feb;11(2):47-8. PMID:15275372
  22. Warner DF, Mizrahi V. The survival kit of Mycobacterium tuberculosis. Nat Med. 2007 Mar;13(3):282-4. PMID:17342138 doi:10.1038/nm0307-282
  23. Lowrie DB, Jackett PS, Ratcliffe NA. Mycobacterium microti may protect itself from intracellular destruction by releasing cyclic AMP into phagosomes. Nature. 1975 Apr 17;254(5501):600-2. PMID:165421
  24. Rickman L, Scott C, Hunt DM, Hutchinson T, Menendez MC, Whalan R, Hinds J, Colston MJ, Green J, Buxton RS. A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor. Mol Microbiol. 2005 Jun;56(5):1274-86. PMID:15882420 doi:10.1111/j.1365-2958.2005.04609.x
Personal tools